by | Jul 18, 2022 | News
Please read Dr. Hudson’s article in the Journal of Medical Internet Research titled, “Demographic and Psychosocial Characteristics Associated With Use of a Prostate Cancer Survivorship Website: Implications From a Multisite Randomized Controlled...
by | Jul 18, 2022 | News
It’s the most infectious strain yet, coming even as many people have written off the pandemic. BA.5, now the dominant coronavirus subvariant in New Jersey and the U.S., has shown resistance to COVID-19 vaccines, making experts nervous. Worse, prior immunity doesn’t...
by | Jul 16, 2022 | News
A study published in Contemporary Clinical Trials that looks at female participation in clinical trials in recent years finds that progress has stalled. Read the Full Article.
by | Jul 15, 2022 | News
Please read Dr. Parekkadan’s article in Experimental Biology and Medicine titled, “Bioactive, full-length parathyroid hormone delivered using an adeno-associated viral vector.” Hypoparathyroidism treatment requires daily recombinant hormone...
by | Jul 15, 2022 | News
Researchers from Rutgers, the University of South Florida and Catholic University of America, whose work has yet to undergo peer review, identified 66 prevalent Mpro mutations located at the nirmatrelvir binding site, where Paxlovid attaches itself to the virus. Many...
